Clinical Trial

Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Trial Details
NCT Number NCT07348172
Lead Sponsor Stanford University
Conditions Drug Liking
Enrollment 100 participants
Start Date 2026-03-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16